retatrutide vision loss Blurry from GLP-1 Medications: What to Know Retatrutide Timeline: When to Expect

This idea of a drug being a quick fix or jump start, those are terms we need to abandon from our lexicon, says Gudzune

Symptoms usually peak during dose escalation and diminish with continued therapy at stable doses

Vasculitic: Nerve ischemia from epineurial vessel inflammation mononeuropathy multiplex pattern

Sometimes the nausea causes people to stop taking these drugs in the first few weeks

GLP-1 medications are typically prescribed for individuals with a body mass index (BMI) of 30 or higher or those with a BMI of 27 or higher who also have weight-related health problems like high blood pressure

These results align with the findings of Wang et al., 28 who reported a reduced incidence of liver cancer among individuals treated with GLP-1 receptor agonists